MAIA Biotechnology, Inc. (MAIA)
- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $1.06
- As of
Kresmion compiles this page from MAIA's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
MAIA Biotechnology, Inc. (MAIA): 3 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-10-06.
See the full MAIA dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for MAIA on one page. Preview it with sample data, then open it live with a free account.
Preview the MAIA dossierActive events for MAIA
- mediumTrend spike
MAIA Biotechnology, Inc. search volume spiked +100 pts, unusual interest
- high13F: funds added
3 tracked funds increased MAIA this 2026Q2, institutional consensus
- medium13F: new position
CITADEL ADVISORS LLC new position in MAIA
- medium13F: new position
RENAISSANCE TECHNOLOGIES LLC new position in MAIA
- medium13F: new position
TWO SIGMA INVESTMENTS, LP new position in MAIA
FREE, NO ACCOUNT
Every event on MAIA, as it fires
You are seeing 5 of 10 events recorded on MAIA since 2026-05-30.
The five above landed across 3 days. The other 5 were recorded on 2 other days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
MAIA positions held by the managers we follow (2026Q2)
What the managers we follow bought and sold in Q2 2026
| Manager / security | Market value | % of reported value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC FundCUSIP 552641102 · 2026Q2 | $599K | 0.00% |
| TWO SIGMA INVESTMENTS, LP FundCUSIP 552641102 · 2026Q2 | $73K | 0.00% |
| CITADEL ADVISORS LLC FundCUSIP 552641102 · 2026Q2 | $36K | 0.00% |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. The share of reported value is each position's value over the sum of the values that manager reported for the quarter; option lines are not in that sum, as on each fund page. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, MAIA
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
More data on MAIA
Related tickers
Cite this data
Kresmion counts the managers it follows that reported a non-option position in MAIA on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on MAIA in the last 180 days.
Upstream: SEC EDGAR filings for MAIA
Kresmion, "MAIA Biotechnology, Inc. (MAIA) institutional holdings and SEC filings", data as of 2026-11-01, https://kresmion.com/research/MAIA. Upstream data: SEC EDGAR filings for MAIA.
Link to this data (HTML):
<a href="https://kresmion.com/research/MAIA">MAIA Biotechnology, Inc. (MAIA) institutional holdings and SEC filings (Kresmion)</a>
Writing about this? Press contact and ready-to-quote figures
Follow MAIA on a live board
Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to MAIA for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.